Artiva Biotherapeutics Inc
ARTV3.010USD
+0.180+6.36%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
3.010USD+3.010After-hours (ET)
73.33MMarket Cap
LossP/E TTM
Artiva Biotherapeutics Inc
3.010
+0.180+6.36%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q2
FY2023Q1
FY2022Q1
Total revenue
-100.00%0.00
--0.00
--0.00
-100.00%0.00
-74.62%251.00K
--3.50M
-26.63%989.00K
--1.35M
Revenue
-100.00%0.00
--0.00
--0.00
-100.00%0.00
-74.62%251.00K
--3.50M
-26.63%989.00K
--1.35M
Operating expenses
50.38%22.17M
--18.27M
--18.34M
5.67%16.19M
-21.06%14.74M
--15.32M
38.64%18.68M
--13.47M
R&D expenses
52.85%17.05M
--13.32M
--13.52M
9.51%12.33M
-24.47%11.16M
--11.26M
52.20%14.77M
--9.71M
Depreciation, depletion, and amortization
4.67%628.00K
--614.00K
--627.00K
12.08%603.00K
0.00%600.00K
--538.00K
259.28%600.00K
--167.00K
Operating profit
-52.99%-22.17M
---18.27M
---18.34M
-36.92%-16.19M
18.07%-14.49M
---11.82M
-45.89%-17.69M
---12.12M
Net non-operating interest income (expenses)
Non-operating interest income
186.77%1.86M
--2.18M
--1.85M
32.81%676.00K
-36.52%650.00K
--509.00K
--1.02M
----
Special income (expenses)
100.00%0.00
--0.00
---977.00K
---2.35M
---268.00K
--0.00
--0.00
--0.00
Other non-operating income (expenses)
-102.72%-4.00K
---5.00K
---6.00K
-25.81%23.00K
377.36%147.00K
--31.00K
---53.00K
----
Income before tax
-45.46%-20.31M
---16.09M
---17.47M
-58.13%-17.84M
16.47%-13.96M
---11.28M
-37.88%-16.72M
---12.12M
Income after tax
-45.46%-20.31M
---16.09M
---17.47M
-58.13%-17.84M
16.47%-13.96M
---11.28M
-37.88%-16.72M
---12.12M
Net income from continuous operations
-45.46%-20.31M
---16.09M
---17.47M
-58.13%-17.84M
16.47%-13.96M
---11.28M
-37.88%-16.72M
---12.12M
Net income attributable to controlling interests
-45.46%-20.31M
---16.09M
---17.47M
-58.13%-17.84M
16.47%-13.96M
---11.28M
-37.88%-16.72M
---12.12M
Net income attributable to common shareholders
-45.46%-20.31M
---16.09M
---17.47M
-58.13%-17.84M
16.47%-13.96M
---11.28M
-37.88%-16.72M
---12.12M
Basic earnings per share
-39.12%-0.83
---0.66
---0.92
-58.12%-0.77
16.47%-0.60
---0.48
-37.88%-0.72
---0.52
Diluted earnings per share
-39.12%-0.83
---0.66
---0.92
-58.12%-0.77
16.47%-0.60
---0.48
-37.88%-0.72
---0.52
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
